Skip to main content
Knight Therapeutics Inc. (TSX:GUD)
Canada flag Canada · Delayed Price · Currency is CAD
6.15
-0.01 (-0.16%)
Mar 9, 2026, 3:20 PM EST

Knight Therapeutics Revenue

Knight Therapeutics had revenue of 121.55M CAD in the quarter ending September 30, 2025, with 31.74% growth. This brings the company's revenue in the last twelve months to 413.85M, up 18.70% year-over-year. In the year 2024, Knight Therapeutics had annual revenue of 371.30M with 13.13% growth.

Revenue (ttm)
413.85M
Revenue Growth
+18.70%
P/S Ratio
1.48
Revenue / Employee
555.50K
Employees
745
Market Cap
611.02M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024371.30M43.11M13.13%
Dec 31, 2023328.20M34.64M11.80%
Dec 31, 2022293.56M50.09M20.57%
Dec 31, 2021243.48M43.96M22.03%
Dec 31, 2020199.52M152.06M320.39%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Canopy Growth 278.39M
Verano Holdings 1.16B
Cresco Labs 899.24M
DRI Healthcare Trust 265.78M
Cipher Pharmaceuticals 69.72M
TerrAscend 417.11M
Cronos Group 200.99M
Organigram Global 279.99M
Revenue Rankings

Knight Therapeutics News

More News